Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain.
about
Familial hemiplegic migraine Ca(v)2.1 channel mutation R192Q enhances ATP-gated P2X3 receptor activity of mouse sensory ganglion neurons mediating trigeminal painA P2X receptor-mediated nociceptive afferent pathway to lamina I of the spinal cordNociceptive transmission and modulation via P2X receptors in central pain syndromeExpression and contribution of satellite glial cells purinoceptors to pain transmission in sensory ganglia: an updateP2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATPIn pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization.P2X receptors in sensory neurons co-cultured with cancer cells exhibit a decrease in opioid sensitivity.Adenosine triphosphate drives head and neck cancer pain through P2X2/3 heterotrimers.P2X receptors: New players in cancer pain.Comprehensive RNA-Seq expression analysis of sensory ganglia with a focus on ion channels and GPCRs in Trigeminal gangliaDHE repression of ATP-mediated sensitization of trigeminal ganglion neurons.Purinoceptors as therapeutic targets for lower urinary tract dysfunction.Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitization.Medicinal chemistry of adenosine, P2Y and P2X receptors.Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain statesUnresolved issues and controversies in purinergic signalling.Subtype-specific regulation of P2X3 and P2X2/3 receptors by phosphoinositides in peripheral nociceptors.Ion channel blockers for the treatment of neuropathic pain.P2X receptor antagonists for pain management: examination of binding and physicochemical properties.P2 receptors for extracellular nucleotides in the central nervous system: role of P2X7 and P2Y₂ receptor interactions in neuroinflammation.VGLUTs in Peripheral Neurons and the Spinal Cord: Time for a Review.P2X3 and P2X2/3 receptor antagonists.2',3'-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agentsLack of evidence for direct phosphorylation of recombinantly expressed P2X(2) and P2X (3) receptors by protein kinase C.Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373.Comparison of P2X and TRPV1 receptors in ganglia or primary culture of trigeminal neurons and their modulation by NGF or serotoninPurinergic signalling.Expression of P2X5 receptors in the rat, cat, mouse and guinea pig dorsal root ganglion.Expression and electrophysiological characteristics of P2X3 receptors in interstitial cells of Cajal in rats with partial bladder outlet obstruction.Electroacupuncture and A-317491 depress the transmission of pain on primary afferent mediated by the P2X3 receptor in rats with chronic neuropathic pain states.P2X receptor ligands and pain.
P2860
Q21203939-8146A82A-E65C-48EC-8462-BF486AB72644Q24806550-4804C9F1-C026-4AA1-AF9C-0E44A1D1D94DQ26745701-B2DCD422-133D-4497-83F3-4C7DEA5FE585Q28287161-6FAA9B28-AE02-402E-90FC-7567DE8E720FQ28585703-441A8897-8353-4C53-96D8-425D769CF866Q30409620-4C820020-E1D0-45C4-907F-5C60DF1D5D79Q33920284-BE8F9A23-EB75-4BC8-9DDC-70E84342518AQ34500229-76FC4795-1711-4237-875A-BE78CCD08910Q34567944-97959D2C-1B1D-4EEA-8645-33C10AB496FEQ35048508-F6DF32BB-E365-41D4-B27A-4B127819CBE8Q35110498-ADA81418-6DDD-45CF-8EB2-1952567ED14FQ35545723-7F1CC96E-82CB-4D4D-886F-31D4D70F9950Q35704108-ECB6E745-C3A4-4409-AC33-C3DE17FACFC1Q35873582-CCE3EC40-0A09-430F-A57E-BDC086594A32Q36807452-A29B7D0D-20D2-4789-9BDF-1AD64577B9C7Q37171511-7AE511F3-A3A9-4ED8-8BFB-29B17DAB1E0FQ37325413-F7DC7006-6566-45A5-900B-FE4E04CFCF51Q37855929-64BCFE61-285A-460F-B789-725EE07A7C73Q37956570-53486501-0FE6-4F65-B17D-0F43F64F1463Q37998945-A401CC28-36AC-44F2-A46C-215C2AFB2C38Q38172176-03521B41-5579-4336-88FF-2281E604BD52Q38172655-75E0F232-0257-4380-9DD9-7A746965F7FBQ39273167-49CD4F61-C22F-42C7-A9C4-06B208AFD3DDQ39959121-2C6B6188-B3F1-42EA-B99B-2A9A89805158Q40221922-3F70F99E-FE20-489D-96CE-8FDB2FF603DEQ42131248-8D4E88A5-9294-4309-B666-79F7B27556E0Q43038390-4B091008-12A1-4744-9E4A-FFFAC6857A9CQ43482625-9ABD3AF7-3923-4B32-8226-1EF6B8B617FFQ46662778-AC6BFE28-7950-4E10-9AA1-347FDC759609Q47840354-58EF8883-5300-42F8-82E3-75EB151CC3F7Q48460330-44F613E4-7A7D-43DD-8E4E-E2E8863C29BB
P2860
Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain.
@ast
Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain.
@en
Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain.
@nl
type
label
Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain.
@ast
Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain.
@en
Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain.
@nl
prefLabel
Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain.
@ast
Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain.
@en
Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain.
@nl
P2860
P356
P1476
Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain.
@en
P2093
Michael F Jarvis
P2860
P304
P356
10.1517/14728222.7.4.513
P407
P577
2003-08-01T00:00:00Z